Correlation Between Anker Innovations and Suzhou Novoprotein

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anker Innovations and Suzhou Novoprotein at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anker Innovations and Suzhou Novoprotein into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anker Innovations Technology and Suzhou Novoprotein Scientific, you can compare the effects of market volatilities on Anker Innovations and Suzhou Novoprotein and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anker Innovations with a short position of Suzhou Novoprotein. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anker Innovations and Suzhou Novoprotein.

Diversification Opportunities for Anker Innovations and Suzhou Novoprotein

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Anker and Suzhou is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Anker Innovations Technology and Suzhou Novoprotein Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Suzhou Novoprotein and Anker Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anker Innovations Technology are associated (or correlated) with Suzhou Novoprotein. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Suzhou Novoprotein has no effect on the direction of Anker Innovations i.e., Anker Innovations and Suzhou Novoprotein go up and down completely randomly.

Pair Corralation between Anker Innovations and Suzhou Novoprotein

Assuming the 90 days trading horizon Anker Innovations Technology is expected to generate 1.06 times more return on investment than Suzhou Novoprotein. However, Anker Innovations is 1.06 times more volatile than Suzhou Novoprotein Scientific. It trades about 0.1 of its potential returns per unit of risk. Suzhou Novoprotein Scientific is currently generating about -0.02 per unit of risk. If you would invest  5,728  in Anker Innovations Technology on October 20, 2024 and sell it today you would earn a total of  4,987  from holding Anker Innovations Technology or generate 87.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Anker Innovations Technology  vs.  Suzhou Novoprotein Scientific

 Performance 
       Timeline  
Anker Innovations 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Anker Innovations Technology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Anker Innovations sustained solid returns over the last few months and may actually be approaching a breakup point.
Suzhou Novoprotein 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Suzhou Novoprotein Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Anker Innovations and Suzhou Novoprotein Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anker Innovations and Suzhou Novoprotein

The main advantage of trading using opposite Anker Innovations and Suzhou Novoprotein positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anker Innovations position performs unexpectedly, Suzhou Novoprotein can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Suzhou Novoprotein will offset losses from the drop in Suzhou Novoprotein's long position.
The idea behind Anker Innovations Technology and Suzhou Novoprotein Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.